News
Positive results for Ipsen’s metastatic pancreatic cancer treatment
Ipsen has announced that the phase 3 NAPOLI 3 trial of Onivyde – a irinotecan liposome injection plus 5 fluorouracil/leucovorin and oxaliplatin – has successfully met its primary endpoint.